2026년 9월 22일•1분 읽기
FDA Approves Irbesartan/Hydrochlorothiazide Combination Tablets (ANDA 077446)
The FDA has approved two prescription oral tablets combining irbesartan and hydrochlorothiazide under ANDA 077446, with multiple labeling supplements approved.